Clinical Trials Directory

Trials / Completed

CompletedNCT03553368

Chest Imaging of Lung Nodule(s) Under High-frequency Non-invasive Ventilation (HF-NIV)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Lausanne Hospitals · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Imaging of chest disorders is mainly achieved by using computed tomography. This is especially the case for detection, morphologic assessment and followup of pulmonary nodules. A positron emission tomography (PET) /CT may be additionally required for lung nodule management in some conditions including a size greater than 8 mm with morphologic or growing characteristics suspicious of malignancy. Magnetic Resonance Imaging (MRI) represents however an interesting alternative diagnostic radiation-free method, in particular owing to the recent development of sequences dedicated to lung parenchyma analysis. A major limitation remains the control of respiratory artefacts. High Frequency non-invasive ventilation, HF-NIV, has the potential to allow chest stabilization and is currently used in the department of radio-oncology at the Lausanne University Hospital. It has been recently applied to perform MRI and PET examinations at end inspiration during an "apnea " generated by the system. Continuous periods of respiratory stabilization of several minutes at end-inspiration are thus obtained, allowing prolonged MR and PET acquisitions with improvement of image quality as observed in our preliminary studies (Beigelman-Aubry et al., Prior et al.). Interestingly, the lung volume explored by using this ventilation technique is similar to that of CT studies, conversely to respiratory gated MR sequences which are currently performed at end-expiration, this potentially generating underevaluation of lung disorders especially at lung bases. The present project aims to determine the impact of HF-NIV in the management of patients with pulmonary nodule(s). After a first step of optimization of acquisition parameters of HF-NIV-MR in healthy volunteers, the performances of MRI and PET/CT (when required) under this ventilation technique will be compared to the current method(s) of reference in cases of pulmonary nodule(s) (CT scan and PET when required) and histological data when available. All MRI and PET/CT (when required) acquisitions will be performed without the ventilation technique, as used in current practice, and with it. The project was completed with an amendment to investigate MRI under continuous positive airway pressure (CPAP). The MR-CPAP combination will be evaluated with optimized parameters in healthy volunteers and compared to free-breathing acquisitions without any device.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHF-NIV-MRMRI data will be acquired with the use of HF-NIV.
DIAGNOSTIC_TESTHF-NIV-PETPET data will be acquired with the use of HF-NIV.
DIAGNOSTIC_TESTMRMRI data will be acquired without the use of any device as a reference.
DIAGNOSTIC_TESTPET/CT breath holdPET/CT data will be acquired in inspiratory breath hold without the use of HF-NIV.
DIAGNOSTIC_TESTCPAP-MRMRI data will be acquired with the use of CPAP.

Timeline

Start date
2018-06-14
Primary completion
2020-03-16
Completion
2020-03-16
First posted
2018-06-12
Last updated
2020-10-19

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03553368. Inclusion in this directory is not an endorsement.